Wird geladen...
Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55–74 years of age
BACKGROUND: The Women’s Health Initiative (WHI) randomized trials found that use of combined estrogen and progestin menopausal hormone therapy (CHT) increases breast cancer risk, but use of unopposed estrogen hormone therapy (EHT) does not. However, several questions regarding the impact of hormone...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4075765/ https://ncbi.nlm.nih.gov/pubmed/24748570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2960-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|